Home Page

BOSTON, May 13, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 13, 2021. The conference call and webcast can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 8694785
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/xqyzme3t

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 4Q FY21 Earnings Release:

https://haemonetics.gcs-web.com/static-files/481f6d1e-dc52-460a-9c68-776987d4e6c1 

Direct link to 4Q FY21 Analytical Tables and Supplemental Information:

https://haemonetics.gcs-web.com/static-files/aedee021-4974-49c9-97bb-aaa441c4fc95 

A replay of the conference call and webcast will be available for one year beginning on May 13, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2021-earnings-release-available-on-investor-relations-website-301290557.html

SOURCE Haemonetics Corporation